All about health

Marpai, Inc. ("Marpai" or the "Company") , an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced...

Today, Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for VELSIPITYtm. A once-daily oral treatment, VELSIPITY is for adult patients with moderately to severely active ulcerative colitis (UC) who have had an...

Manna Tree, a global private equity firm committed to improving human health through nutrition, today announced the strategic additions of Adam Whitehead as Director of Investor Relations and Attie Hoffman as Vice President of Strategic...

Innovative Community Oncology Practices (ICOP) is proud to announce its endorsement of Oncentric as the preferred healthcare technology and services provider for all its member practices. This partnership aims to improve health outcomes and enhance...

The American Institute of Ultrasound in Medicine (AIUM) closed its UltraCon2024 event in Austin, TX, by honoring individuals who advance the field of medical imaging and ultrasound and improve patient outcomes across the globe....

Doctor's Best Inc., a leading nutritional supplement company, announced today their launch of two new products, Glutathione + Milk Thistle with Setria® and Boswellia + UC-II®....

Novocure today announced the results of the METIS phase 3 clinical trial in brain metastases from non-small cell lung cancer (NSCLC) will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, to be held...

In observance of Parkinson's Disease Awareness Month, Quest Research Institute (Quest), a site within Alcanza Clinical Research's network located in Detroit, emphasizes the importance of raising awareness about Parkinson's disease (PD), recognizing...

Recently, GenScript Biotech Corporation (HK.1548), a world leader in technologies and services for life science R&D and manufacture, released its 2023 Environmental, Social, and Governance (ESG) report. This report showcases the company's dedicated...

Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of 4.0% from 2024 to 2029 according to a new report by MarketsandMarketstm. Similarly, the vaccines...

Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that updated Phase 1/2 data for AU-007 will be presented at the American Society...

A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in Chicago, Illinois. The COVID-19 Monument of Honor, Remembrance, and Resilience...

Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced clinical data from the pivotal Phase 2 study of PRGN-2012 AdenoVerse immunotherapy...

The two poster presentations will report -first combination data from the Phase 1/2a study with BI-1808 in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), as well as an update on monotherapy armcombination data from the...

Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Kwan-Ho "Alex" Chung, Ph.D. has joined the firm's Intellectual Property practice group and Life Sciences industry team in Washington, D.C. Chung was most recently a partner at...

For nearly 40 years Burke Williams has been an innovator and leader in the luxury day spa industry, and in 2024 the company is continuing to deliver relaxing, rejuvenating experiences for guests that truly transform their day....

The Veterinary Innovation Council (VIC) today announced the launch of new resources to address the nationwide problem of access to veterinary care and new comprehensive services to help veterinarians reach underserved patients. Formed in 2015 by the...

Nature's Sunshine Products , a leading natural health and wellness company of premium-quality herbal and nutritional products, today released its 2023 Comprehensive Impact Report. The report showcases Nature's Sunshine's advancements over the past 12...

Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, today announced that data from its Phase 2 study of...

Public health researchers have a new, powerful tool from data and AI provider SAS to analyze the National Institutes of Health's All of Us Research Program's large and diverse data set. The NIH has added SAS Analytics Pro on SAS® Viya® to the All of...

HighField Biopharmaceuticals, a clinical stage immuno-oncology company using lipid-based therapeutics to treat cancer, announced today that two HighField abstracts have been accepted with one poster presentation at the American Society of Clinical...

Bicycle Therapeutics plc , a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the acceptance of two abstracts for poster presentation...

Dizal (SSE:688192), a biopharmaceutical company committed to developing groundbreaking new medicines for the treatment of cancer and immunological diseases, announced today that two abstracts featuring the latest data on sunvozertinib in non-small...

The American Association of Critical-Care Nurses (AACN) has published "AACN Standards for Appropriate Staffing in Adult Critical Care," the specialty's first, action-oriented staffing standards. Appropriate staffing has long been one of the "AACN...

Nuvation Bio Inc. , a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced that updated data from the Phase 2 TRUST-I...

AffyImmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, today announced an abstract detailing its affinity-tuned CAR T therapy AIC100 will be presented at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, held...

SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group, today announced it will present a Trial-in-Progress poster on the DUET-01 Phase 1/2 study of BOXR1030 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting...

After more than 60 years of researching the power of plants in Germany, Bayer Consumer Health is introducing Iberogasttm, a plant-based digestive relief product, to the United States. Formulated with a clinically proven, proprietary six-herb blend,...

Agenus Inc. ("Agenus") , a leader in developing novel immunological agents to treat various cancers, today announced an upcoming presentation from the Phase 1b trial of botensilimab in combination with balstilimab ("BOT/BAL") in patients with...

IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that interim results from the investigator-sponsored Phase 2 trial evaluating darovasertib safety...